Phase 4 VTE Clinical Trials

6 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 16 of 6 trials

Not Yet Recruiting
Phase 4

Coagulation assessment of sublingual oestrogen (CASE) trial comparison of clotting profile and risk in transgender females on oral vs sublingual estrogen for gender affirming hormonal therapy

Gender affirming estrogen therapyVenous Thromboembolism (VTE)
Rita Upreti - Monash health30 enrolled1 locationACTRN12625000730404
Recruiting
Phase 4

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

Venous Thromboembolism (VTE)
University Hospital, Brest2,400 enrolled18 locationsNCT06845423
Recruiting
Phase 4

Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis

Intensive Care MedicineVenous ThromboembolismVenous Thromboembolism (VTE)
Science Valley Research Institute50 enrolled1 locationNCT06958588
Terminated
Phase 4

A clinical trial to determine if aspirin is as effective and safe as low molecular weight heparin in preventing lung and leg clots after total hip or knee replacement surgery

Venous Thromboembolic Events (VTE) after Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)
University of New South Wales15,562 enrolled1 locationACTRN12618001879257
Completed
Phase 3Phase 4

Assessment of microbleeding after prophylaxis with enoxaparin or rivaroxaban against venous thromboembolic disease following hip and knee surgery

Prevention and treatment of venous thromboembolism (VTE); comprising deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip and knee arthroplasty.
Launceston General Hospital1,060 enrolled1 locationACTRN12609000762257
Recruiting
Phase 4

Thrombophilia in Pregnancy Prophylaxis Study: a multicentre, multinational, randomised controlled trial of prophylactic low molecular weight heparin in high-risk pregnant thrombophilic women.

Venous thromboembolism (VTE) and placenta mediated pregnancy complications in thrombophilic women.
The Ottawa Health Research Institute385 enrolled32 locationsACTRN12608000446369